JP2025513786A5 - - Google Patents

Info

Publication number
JP2025513786A5
JP2025513786A5 JP2024559196A JP2024559196A JP2025513786A5 JP 2025513786 A5 JP2025513786 A5 JP 2025513786A5 JP 2024559196 A JP2024559196 A JP 2024559196A JP 2024559196 A JP2024559196 A JP 2024559196A JP 2025513786 A5 JP2025513786 A5 JP 2025513786A5
Authority
JP
Japan
Prior art keywords
computing system
training
additional
individual
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024559196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513786A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/065560 external-priority patent/WO2023197004A1/en
Publication of JP2025513786A publication Critical patent/JP2025513786A/ja
Publication of JP2025513786A5 publication Critical patent/JP2025513786A5/ja
Pending legal-status Critical Current

Links

JP2024559196A 2022-04-07 2023-04-07 無細胞核酸分子のメチル化状態に基づいた腫瘍の存在の検出 Pending JP2025513786A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263328602P 2022-04-07 2022-04-07
US63/328,602 2022-04-07
US202263336852P 2022-04-29 2022-04-29
US63/336,852 2022-04-29
PCT/US2023/065560 WO2023197004A1 (en) 2022-04-07 2023-04-07 Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules

Publications (2)

Publication Number Publication Date
JP2025513786A JP2025513786A (ja) 2025-04-30
JP2025513786A5 true JP2025513786A5 (https=) 2026-04-07

Family

ID=86328669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024559196A Pending JP2025513786A (ja) 2022-04-07 2023-04-07 無細胞核酸分子のメチル化状態に基づいた腫瘍の存在の検出

Country Status (5)

Country Link
US (1) US20250273295A1 (https=)
EP (1) EP4504971A1 (https=)
JP (1) JP2025513786A (https=)
CA (1) CA3246524A1 (https=)
WO (1) WO2023197004A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115457361A (zh) * 2022-09-19 2022-12-09 京东方科技集团股份有限公司 分类模型获取方法、表达类别确定方法、装置、设备及介质
US20250125050A1 (en) * 2023-10-13 2025-04-17 Tempus Ai, Inc. Systems and methods for molecular residual disease liquid biopsy assay
GB202317261D0 (en) * 2023-11-10 2023-12-27 Cancer Research Tech Ltd Methods for determining cancers
WO2025106275A1 (en) * 2023-11-15 2025-05-22 Guardant Health, Inc. Minimum residual disease (mrd) detection in early stage cancer using urine
WO2025155784A1 (en) * 2024-01-18 2025-07-24 Grail, Inc. Systems and methods to identify clonal hematopoiesis related methylation signatures
WO2026076332A1 (en) * 2024-10-03 2026-04-09 Guardant Health, Inc. Methods involving multi-modal tumor variant identification and tracking of tumor molecules

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US20030017081A1 (en) 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
WO2003046146A2 (en) 2001-11-28 2003-06-05 Applera Corporation Compositions and methods of selective nucleic acid isolation
ATE443765T1 (de) 2003-03-21 2009-10-15 Santaris Pharma As Analoga kurzer interferierender rna (sirna)
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
GB2559073A (en) 2012-06-08 2018-07-25 Pacific Biosciences California Inc Modified base detection with nanopore sequencing
CN104781421B (zh) 2012-09-04 2020-06-05 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
EP4358097A1 (en) 2014-07-25 2024-04-24 University of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
WO2018009723A1 (en) 2016-07-06 2018-01-11 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
MX2019007444A (es) 2016-12-22 2019-08-16 Guardant Health Inc Metodos y sistemas para analisis de moleculas de acido nucleico.
WO2020160414A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
ES2994567T3 (en) * 2019-02-05 2025-01-27 Grail Inc Detecting cancer, cancer tissue of origin, and/or a cancer cell type
US20210407623A1 (en) * 2020-03-31 2021-12-30 Guardant Health, Inc. Determining tumor fraction for a sample based on methyl binding domain calibration data
EP4153771A4 (en) 2020-05-19 2024-07-24 The Trustees of the University of Pennsylvania COMPOSITIONS AND METHODS FOR CARBOXYMETHYLATION OF DNA CYTOSINE
CA3225385A1 (en) 2021-07-12 2023-01-19 The Trustees Of The University Of Pennsylvania Modified adapters for enzymatic dna deamination and methods of use thereof for epigenetic sequencing of free and immobilized dna

Similar Documents

Publication Publication Date Title
JP2025513786A5 (https=)
Ni et al. Benchmarking of Nanopore R10. 4 and R9. 4.1 flow cells in single-cell whole-genome amplification and whole-genome shotgun sequencing
AU2023251452B2 (en) Validation methods and systems for sequence variant calls
JP2025026936A5 (https=)
JP2024012567A (ja) 無細胞核酸の多重解像度分析のための方法
Sloma et al. Improving RNA secondary structure prediction with structure mapping data
JP2021513364A5 (https=)
Miller et al. Improving reliability and absolute quantification of human brain microarray data by filtering and scaling probes using RNA-Seq
KR20200011446A (ko) 서열-특정 오류(sse)를 유발시키는 서열 패턴을 식별하기 위한 심층 학습-기반 프레임워크
KR20170000744A (ko) 유전자의 복제수 변이(cnv)를 분석하는 방법 및 장치
CN116386718A (zh) 检测拷贝数变异的方法、设备和介质
KR20250036077A (ko) 카피수 변이체 유전자형을 결정하기 위한 방법 및 시스템
US20210272651A1 (en) Method for determining a quantification of old and new rna
JP2024519082A5 (https=)
JP7532396B2 (ja) パートナー非依存性遺伝子融合検出のための方法
JP2016184185A5 (https=)
CN108893533B (zh) 用于预测或辅助预测肺部辐射后患放射性肺炎风险的试剂盒
JP2022527316A5 (https=)
Krachunov et al. Machine learning models in error and variant detection in high-variation high-throughput sequencing datasets
JP7362901B2 (ja) 塩基のメチル化度の算出方法及びプログラム
EP4297037A1 (en) Device for determining an indicator of presence of hrd in a genome of a subject
Gordon et al. A new expectation-maximization statistical test for case-control association studies considering rare variants obtained by high-throughput sequencing
CN121393536A (zh) 基于群体样本eQTL和单细胞eQTL的数据分析方法及系统
JP2026052130A (ja) 情報処理装置、情報処理方法、および情報処理プログラム
Dago et al. RNA-Seq evaluating several custom microarrays background correction and gene expression data normalization systems